Experimental peptide targets Covid-19
Computational modeling yields a protein fragment that could bind to coronavirus spike proteins and destroy them.
Computational modeling yields a protein fragment that could bind to coronavirus spike proteins and destroy them.
MIT researchers pinpoint mechanism and demonstrate that drugs could help.
Automated tabletop machine could accelerate the development of novel drugs to treat cancer and other diseases.
Study: Vaccines find more success in development than any other kind of drug, but have been relatively neglected in recent decades.
Report offers guidelines to help prevent viruses from tainting biopharmaceutical drugs.
Studies of drug absorption in the small intestine could help researchers identify medicines that can be taken orally.
The Audacious Project commitment will support the development of new classes of antibiotics to treat the world’s deadliest bacterial pathogens.
An eminent microbiologist, Demain conducted groundbreaking antibiotics research and mentored hundreds of young scientists.
MIT chemists are testing a protein fragment that may inhibit coronaviruses’ ability to enter human lung cells.
Neuroscientists identify genes that modulate the disease’s toxic effects.
Deborah Hung shares research strategies to combat tuberculosis as part of the Department of Biology's IAP seminar series on microbes in health and disease.
A key part of J-Clinic, the MIT-Takeda Program will create educational opportunities and support cutting-edge research to positively impact human health.
Three innovative research projects in literature, plant epigenetics, and chemical engineering will be supported by Professor Amar G. Bose Research Grants.
Biologists devise an efficient method to prepare fluorescently tagged proteins and simulate their native environment.
Using specialized liver cells, a new test can quickly detect potentially cancer-causing DNA damage.